17/09/2025
ZR MedTech: Driven by innovation, devoted to regeneration
😉Who We Are
Established in 2016, ZR MedTech is a leading innovator in the field of high-tech surgical grafts and soft tissue repair. With our operational headquarters in Shanghai and advanced manufacturing center in Jiangsu Province, we combine global vision with world-class production capabilities to address critical unmet needs in surgery.
🔖Our Story: From a Clinical Challenge to a Global Solution
Fifteen years ago, a profound challenge from a surgeon sparked our journey. He revealed the frustrating absence of long-term solutions for tissue defects, which left countless patients suffering from recurrence and the consequences of biodegraded tissues.
This insight became our mission🌟: to revolutionize patient outcomes in surgical tissue reconstruction through groundbreaking biomaterial innovation.
Through years of continuous development and invaluable partnerships with clinicians and scientists, our technology has evolved. Our deepening understanding of biology has fueled non-stop innovation, allowing us to constantly iterate and advance.
🌟The ExceBM® Platform: Engineered for Regenerative Healing
At the core of our breakthrough technology is the ExceBM® platform, which leverages our proprietary and exclusive capabilities in advanced basement membrane biomaterials. This enables us to develop a new generation of biologic grafts that closely mimic the body's natural extracellular matrix, promoting effective healing and integration.
🌟Our state-of-the-art manufacturing facility features advanced automated production lines that follows the international manufacturing standards of ISO 13485 and MDSAP.
Comprehensive Portfolio for Surgical Excellence
In the past 10 years, we have built up a pipeline of over 10 Class III implantable medical devices derived from our ExceBM® platform, serving multiple surgical specialties:
●Hernia and Abdominal Wall Repair
●Neurosurgery
●Dermatology
●Gynecology
●Otolaryngology
●Orthopedics
●Medical Aesthetics
Four of our flagship products - ExceReg® Biological Surgical Graft, ExcePev™ Biological Pelvic Graft, ExceReg® Plus, and ExceReg® Guard - have been accepted into the Innovation Approval Procedure (China Breakthrough Devices), recognizing their significant clinical value and innovative nature.
Global Impact and Future Vision
🐾To date, ZR MedTech products have supported thousands of clinicians in treating millions of patients worldwide.
🐾With 5 international patents and over 60 domestic patents filed or granted, and supported by prestigious research programs including the National Key R&D Program, we continue to push the boundaries of what's possible in tissue regeneration.
🎇Our vision is to become a driving global force in surgical tissue reconstruction and critical care management through continuous innovation across multiple dimensions - from material science to digital solutions - creating a future where every patient has access to the best possible regenerative care.
